Radioligand binding assay of progesterone receptors in the primate corpus luteum after in vivo treatment with the 3 β-hydroxysteroid dehydrogenase inhibitor, trilostane

O. D. Slayden, M. B. Zelinski-Wooten, R. L. Stouffer, R. M. Brenner

    Research output: Contribution to journalArticle

    12 Scopus citations

    Abstract

    We and others have detected progesterone receptors (PR) in the primate (macaque and human) corpus luteum by immunocytochemistry. However, we have been unable to measure PR in the corpus luteum by conventional ligand binding assay, presumably because high endogenous concentrations of progesterone (P) in luteal tissue prevented specific binding of radiolabeled hormone to PR during the assays. To test this hypothesis, we treated monkeys with the 3 β-hydroxysteroid dehydrogenase inhibitor, Trilostane, to reduce levels of endogenous P before conducting binding assays for PR in luteal tissue. To obtain adequate tissue for saturation analysis, rhesus monkeys (n = 6) were superovulated by treating them with hFSH beginning at menses (day 1) for 6 days, then with hFSH and hLH (days 6-9), followed by hCG (day 10). Trilostane (600 mg) was given 5 days after hCG treatment (day 15), and binding assays were conducted 18 h later. Trilostane significantly reduced mean (± SE) serum levels of P from 97.8 ± 16 to 2.7 ± 1.3 nmol/L within 18 h (P < 0.001). Strong nuclear staining of PR was detected by immunocytochemistry in both Trilostane-treated and control (not Trilostane-treated) tissue, but ligand binding was measurable only in Trilostane-treated monkeys. Scatchard transformations of saturation curves revealed high affinity binding of [3H] R5020 in luteal cytosol and nuclear extracts with an approximate dissociation constant (Kd) of 4.8 and 1.37 nmol/L, respectively. Also, the PR-specific monoclonal antibody, JZB-39, shifted a [3H]R5020-bound luteal macromolecule on sucrose gradients. Mean cytosolic and nuclear binding of [3H]R5020 were 0.31 ± 0.09 and 0.06 ± 0.02 fmol/μg DNA, respectively. Similar binding of [3H]R5020 was demonstrated in corpora lutea obtained during spontaneous menstrual cycles after Trilostane treatment (n = 3). These results show unequivocally that the PR in macaque luteal tissue can bind P with high affinity and suggest a receptor-mediated action of P in the primate corpus luteum.

    Original languageEnglish (US)
    Pages (from-to)620-626
    Number of pages7
    JournalJournal of Clinical Endocrinology and Metabolism
    Volume79
    Issue number2
    DOIs
    StatePublished - Aug 1994

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Biochemistry
    • Endocrinology
    • Clinical Biochemistry
    • Biochemistry, medical

    Fingerprint Dive into the research topics of 'Radioligand binding assay of progesterone receptors in the primate corpus luteum after in vivo treatment with the 3 β-hydroxysteroid dehydrogenase inhibitor, trilostane'. Together they form a unique fingerprint.

  • Cite this